A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine With or Without Oxaliplatin With Preoperative Radiation Therapy And Continuous Intravenous Infusion Of 5-Fluorouracil With or Without Oxaliplatin In The Treatment Of Patients With Operable Carcinoma Of The Rectum.
Latest Information Update: 29 Jun 2022
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 24 Jun 2022 Results assessing health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer published in the Cancer
- 22 Mar 2016 Planned end date changed from 1 Jan 2016 to 1 May 2016, as reported by ClinicalTrials.gov.
- 12 Aug 2015 Planned End Date changed from 1 Aug 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov record.